Article
Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
Cancer research - 15 Mar 2005
Aplenc Richard, Thompson Jennifer, Han Peggy, La Mei, Zhao Huaqing, Lange Beverly, Rebbeck Timothy
Abstract excerpt
A significant portion of patients treated for pediatric acute lymphoblastic leukemia (ALL) relapse. We hypothesized that common polymorphisms with moderate effect sizes and large attributive risks could explain an important fraction of ALL relapses. Methylenetetrahydrofolate reductase (MTHFR) is central to folate metabolism and has two common functional polymorphisms (C677T and A1298G). Methotrexate (MTX), which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
